Molecular pharmacophore selectivity studies, virtual screening, and in silico ADMET analysis of GPCR antagonists

作者: Hany Emary Ali Ahmed , Mohamed F Zayed , Saleh Ihmaid , None

DOI: 10.1007/S00044-015-1389-6

关键词: Molecular descriptorG protein-coupled receptor5-HT2A receptorIn silicoVirtual screeningDrug discoveryPharmacophoreChemistryCombinatorial chemistryRational design

摘要: The G protein-coupled receptors (GPCRs), especially amine type, comprise the largest family of proteins targeted by drug discovery. One major hurdles in design safe and effective drugs targeting GPCRs is finding ligands that are highly selective for a specific receptor subtype. To gain insights into structural basis ligand subtype selectivity within (D1, D2, D3, D4, Alpha1, 5HT1a, 5HT2a), we generated 3D pharmacophore models all seven subtypes. performance molecular descriptors rational to maximize GPCR antagonists with different profile investigated this publication. Different family- target-specific were built applied searching evaluate their identifying target-selective hits. Five prediction obtained as potential hits using virtual screening protocol ZINC database. This study multiple mapping provided deep insight subtype-selectivity determinants can be used novel tool discovery potent which could treatment GPCR-linked diseases.

参考文章(46)
Jolanta Obniska, Małgorzata Dybała, Andrzej J Bojarski, Marcin Kołaczkowski, Sijka Charakchieva-Minol, Krystyna Nedza, Synthesis, anticonvulsant properties and 5-HT1A/5-HT2A receptor affinity of new N-[(4-arylpiperazin-1-yl)-propyl]-2-aza-spiro[4.4]nonane and [4.5]decane-1,3-dione derivatives. Pharmacological Reports. ,vol. 57, pp. 336- 344 ,(2005)
Christine Brefel-Courbon, Claire Thalamas, H??l??ne Peyro Saint Paul, Jean-Michel Senard, Jean-Louis Montastruc, Olivier Rascol, ??2-Adrenoceptor Antagonists CNS Drugs. ,vol. 10, pp. 189- 207 ,(1998) , 10.2165/00023210-199810030-00004
Bruce E Maryanoff, David F McComsey, Gregory E Martin, Richard P Shank, Azepinoindole derivatives with high affinity for brain dopamine and serotonin receptors. Bioorganic & Medicinal Chemistry Letters. ,vol. 8, pp. 983- 988 ,(1998) , 10.1016/S0960-894X(98)00138-3
Suwanna Vangveravong, Elizabeth McElveen, Michelle Taylor, Jinbin Xu, Zhude Tu, Robert R. Luedtke, Robert H. Mach, Synthesis and characterization of selective dopamine D2 receptor antagonists Bioorganic & Medicinal Chemistry. ,vol. 14, pp. 815- 825 ,(2006) , 10.1016/J.BMC.2005.09.008
Laura Bettinetti, Karin Schlotter, Harald Hübner, Peter Gmeiner, Interactive SAR Studies: Rational Discovery of Super-Potent and Highly Selective Dopamine D3 Receptor Antagonists and Partial Agonists Journal of Medicinal Chemistry. ,vol. 45, pp. 4594- 4597 ,(2002) , 10.1021/JM025558R
V. Šukalović, Deana Andrić, G. Roglić, Sladjana Kostić-Rajačić, A. Schrattenholz, V. Šoškić, Synthesis, dopamine D2 receptor binding studies and docking analysis of 5-[3-(4-arylpiperazin-1-yl)propyl]-1H-benzimidazole, 5-[2-(4-arylpiperazin-1-yl)ethoxy]-1H-benzimidazole and their analogs European Journal of Medicinal Chemistry. ,vol. 40, pp. 481- 493 ,(2005) , 10.1016/J.EJMECH.2004.10.006
Ao Zhang, Yi Zhang, Alan R. Branfman, Ross J. Baldessarini, John L. Neumeyer, Advances in Development of Dopaminergic Aporphinoids Journal of Medicinal Chemistry. ,vol. 50, pp. 171- 181 ,(2007) , 10.1021/JM060959I
Laura Betti, Maurizio Botta, Federico Corelli, Monia Floridi, Gino Giannaccini, Laura Maccari, Fabrizio Manetti, Giovannella Strappaghetti, Andrea Tafi, Stefano Corsano, α1-Adrenoceptor Antagonists. 4.1Pharmacophore-Based Design, Synthesis, and Biological Evaluation of New Imidazo-, Benzimidazo-, and Indoloarylpiperazine Derivatives Journal of Medicinal Chemistry. ,vol. 45, pp. 3603- 3611 ,(2002) , 10.1021/JM011077G
Kevin J Hodgetts, Andrzej Kieltyka, Robbin Brodbeck, Jennifer N Tran, Jan W.F Wasley, Andrew Thurkauf, 6-(4-Benzylpiperazin-1-yl)benzodioxanes as selective ligands at cloned primate dopamine D4 receptors Bioorganic & Medicinal Chemistry. ,vol. 9, pp. 3207- 3213 ,(2001) , 10.1016/S0968-0896(01)00226-7
J. Mason, A. Good, E. Martin, 3-D pharmacophores in drug discovery Current Pharmaceutical Design. ,vol. 7, pp. 567- 597 ,(2001) , 10.2174/1381612013397843